Search research articles
Contact Us
Filters
Showing results (781-790 of 837) with videos related to
Page
of 84
Sort By:
The American Journal of Gastroenterology
|
June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch
Edward L Barnes, Laura Raffals, Taha Qazi, et al.
Gut
|
February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panés, William J Sandborn, Stefan Schreiber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 12, 2020
Coronavirus Disease 2019 (COVID-19) Clinical Trial Oversight at a Major Academic Medical Center: Approach of Michigan Medicine
Kayte Spector-Bagdady, Peter D R Higgins, Keith D Aaronson, et al.
American Journal of Obstetrics & Gynecology MFM
|
December 21, 2020
Defining the upper limit of the second stage of labor in nulliparous patients
Catherine L Finnegan, Naomi Burke, Fionnuala Breathnach, et al.
American Journal of Obstetrics and Gynecology
|
July 28, 2012
Placental pathology, birthweight discordance, and growth restriction in twin pregnancy: results of the ESPRiT Study
Etaoin M Kent, Fionnuala M Breathnach, John E Gillan, et al.
The Lancet. Gastroenterology & Hepatology
|
September 8, 2023
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
Séverine Vermeire, Silvio Danese, Wen Zhou, et al.
Journal of Crohn'S & Colitis
|
February 5, 2019
CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's Disease
Shrinivas Bishu, Mohammed El Zaatari, Atsushi Hayashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 16, 2025
Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy
Charlotte Larson, Jeffrey A Berinstein, Nicholas Tedesco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2021
Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review
Calen A Steiner, Jeffrey A Berinstein, Jeremy Louissaint, et al.
Gastroenterology
|
November 8, 2021
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease
Bruce E Sands, Laurent Peyrin-Biroulet, Jaroslaw Kierkus, et al.
Page
of 84
Search research articles
Search
Showing results (781-790 of 837) with videos related to
Sort By:
Page
of 84
The American Journal of Gastroenterology
|
June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch
Edward L Barnes, Laura Raffals, Taha Qazi, et al.
Gut
|
February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panés, William J Sandborn, Stefan Schreiber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 12, 2020
Coronavirus Disease 2019 (COVID-19) Clinical Trial Oversight at a Major Academic Medical Center: Approach of Michigan Medicine
Kayte Spector-Bagdady, Peter D R Higgins, Keith D Aaronson, et al.
American Journal of Obstetrics & Gynecology MFM
|
December 21, 2020
Defining the upper limit of the second stage of labor in nulliparous patients
Catherine L Finnegan, Naomi Burke, Fionnuala Breathnach, et al.
American Journal of Obstetrics and Gynecology
|
July 28, 2012
Placental pathology, birthweight discordance, and growth restriction in twin pregnancy: results of the ESPRiT Study
Etaoin M Kent, Fionnuala M Breathnach, John E Gillan, et al.
The Lancet. Gastroenterology & Hepatology
|
September 8, 2023
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
Séverine Vermeire, Silvio Danese, Wen Zhou, et al.
Journal of Crohn'S & Colitis
|
February 5, 2019
CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's Disease
Shrinivas Bishu, Mohammed El Zaatari, Atsushi Hayashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 16, 2025
Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy
Charlotte Larson, Jeffrey A Berinstein, Nicholas Tedesco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2021
Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review
Calen A Steiner, Jeffrey A Berinstein, Jeremy Louissaint, et al.
Gastroenterology
|
November 8, 2021
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease
Bruce E Sands, Laurent Peyrin-Biroulet, Jaroslaw Kierkus, et al.
Page
of 84